The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 trial of the oncolytic virus SVV-001 in combination with nivolumab and ipilimumab in patients with poorly differentiated neuroendocrine carcinomas or well-differentiated grade 3 neuroendocrine tumors.
 
Aman Chauhan
Stock and Other Ownership Interests - Elicio Therapeutics; Revolution Medicines
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Boehringer Ingelheim; Crinetics Pharmaceuticals; Curium Pharma; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck KGaA (Inst); Nano Therapeutics (Inst); Seneca Therapeutics (Inst); TerSera (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
 
Isildinha Reis
No Relationships to Disclose
 
Chinmay Jani
No Relationships to Disclose
 
Rakhi Modak
No Relationships to Disclose
 
Daniel Cortes
No Relationships to Disclose
 
Jaime Merchan
Consulting or Advisory Role - Merck
Research Funding - Arcus Biosciences (Inst); BioNTech (Inst); Corvus Pharmaceuticals (Inst); DynamiCure Biotechnology (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); IMUGENE (Inst); Kalivir Immunotherapeutics (Inst); Merck (Inst); ModeX Therapeutics Inc (Inst); Peloton Therapeutics (Inst); Replimune (Inst); Rubius Therapeutics (Inst); Seattle Genetics/Astellas (Inst); Sillajen (Inst); Tizona Therapeutics, Inc. (Inst); Tocagen (Inst); Trishula Therapeutics (Inst); Tubulis GmbH (Inst); Vyriad (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Paul Hallenbeck
Employment - Seneca Therapeutics
 
Gilberto Lopes
No Relationships to Disclose
 
Peter Hosein
Consulting or Advisory Role - FibroGen; Revolution Medicines